Panel Session
Medicines manufacturing is entering a decisive new era—one defined by intelligent systems, autonomous workflows, and data‑driven decision‑making. This session explores how AI, machine learning, automation, and digitalisation are reshaping the way biopharmaceuticals are developed, scaled, and delivered.